A Three-Month Clinical Trial on the Efficacy of Hyaluronic Acid Adjunctive Non-Surgical Therapy for Periodontitis in Patients with Type 2 Diabetes Mellitus
Open Access
- 4 November 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (11) , 2516
Abstract
Background/Objectives: Conventional periodontal treatment for patients with diabetes has shown promising results, primarily focusing on glycated hemoglobin (HbA1c) levels as an endpoint measure. The properties of hyaluronic acid (HA) have been harnessed in various periodontal therapies, and it is a promising agent also in a non-surgical approach. The aim of this clinical trial was to assess the efficacy of hyaluronic acid in a local adjunctive non-surgical treatment for periodontitis in patients with type 2 diabetes. Methods: Eighty adult participants with well-controlled type 2 diabetes (HbA1c 7% (53 mmol/mol) or less) took part in the trial. The clinical parameters of periodontitis as well as the glycated hemoglobin (HbA1c) levels were evaluated, and an analysis of the potential differences between the control (placebo) and intervention (HA) groups was performed. Results/Conclusions: A decrease in all the clinical values of periodontitis after treatment was observed in the vast majority of patients in both groups. Differences in the clinical parameters were observed 12 weeks after the intervention between the patients in the placebo and HA therapy groups. Bleeding on probing (BoP) was reduced in the control group to 15–25% and was approximately 5.5% more in the intervention group (9.5–18.25%). The clinical attachment level (CAL) decreased 1 mm more in the HA therapy group (1–2 mm) than in the no adjunctive treatment group (2–3 mm). The probing depth (PD) was reduced similarly in both groups (3–3.75 mm). Due to the bilateral relationship between diabetes and periodontitis, healthcare professionals seek advancements in managing periodontal inflammation. The results of this study indicate that non-surgical periodontal treatment with HA as an adjunctive agent is worth considering in the therapy for patients with diabetes.Keywords
Funding Information
- Jagiellonian University Medical College (1072.6120.47.2022)
This publication has 33 references indexed in Scilit:
- Oral microbiota in periodontitis patients with and without type 2 diabetes mellitus and their shifts after the nonsurgical periodontal therapyHeliyon, 2023
- Effect of photobiomodulation adjunct to periodontal therapy on individuals with type 2 diabetes mellitus regarding periodontal clinical parameters: a systematic review and meta-analysisLasers in Medical Science, 2023
- Nonsurgical periodontal treatment improved the type 2 diabetes mellitus status in smokers: A randomized controlled trialDiabetes Research and Clinical Practice, 2022
- Treatment of periodontitis for glycaemic control in people with diabetes mellitusCochrane Database of Systematic Reviews, 2022
- Biological molecules in dental applications: hyaluronic acid as a companion biomaterial for diverse dental applicationsHeliyon, 2020
- Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trialThe Lancet Diabetes & Endocrinology, 2018
- Effect of nonsurgical periodontal therapy (with or without oral doxycycline delivery) on glycemic status and clinical periodontal parameters in patients with prediabetes: a short-term longitudinal randomized case–control studyClinical Oral Investigations, 2014
- Periodontitis and diabetes: a two-way relationshipDiabetologia, 2011
- Diabetes mellitus and periodontitis: a tale of two common interrelated diseasesNature Reviews Endocrinology, 2011
- Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trialClinical Oral Investigations, 2011